SCHEMBL17345995

SCHEMBL17345995

CCN(CC)CCN(CCCSc1ccccc1)Cc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 1/20 0.59
KCNH2 Q12809 2/20 0.47
CHRM2 P08172 1/20 0.47
HTR1A P08908 1/20 0.47
ADRA2A P08913 1/20 0.47
CHRM1 P11229 1/20 0.47
DRD1 P21728 1/20 0.47
SLC6A2 P23975 1/20 0.47
SLC6A4 P31645 1/20 0.47
ADRA1A P35348 1/20 0.47
OPRM1 P35372 1/20 0.47
DRD3 P35462 1/20 0.47
SLC6A3 Q01959 1/20 0.47
MAOB P27338 3/20 0.45
BCHE P06276 4/20 0.44
ACHE P22303 4/20 0.44
KDM4E B2RXH2 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
CNR2 P34972 1/20 0.41
SIGMAR1 Q99720 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17346006 0.91 BCHE (0.49) SLC2A1BCHE
SCHEMBL17346020 0.90 SLC2A1 (0.48) SLC2A1KCNH2CHRM2HTR1AADRA2A
SCHEMBL17346007 0.90 MAPT (0.47) SLC2A1KCNH2OPRM1DRD3BCHE
SCHEMBL17346123 0.88 CALM1 (0.49) SLC2A1KCNH2CHRM2ADRA2ADRD1
SCHEMBL17345981 0.87 SLC2A1 (0.51) SLC2A1KCNH2CHRM2HTR1AADRA2A
SCHEMBL17346044 0.87 ACKR3 (0.49) SLC2A1MAOBKDM4ESMN1; SMN2SIGMAR1
SCHEMBL17345931 0.85 HTT (0.47) SLC2A1SIGMAR1
SCHEMBL17346047 0.84 SLC2A1 (0.41) SLC2A1KCNH2CHRM2HTR1AADRA2A
SCHEMBL17345982 0.83 FDPS (0.47) SLC2A1MAOBBCHESIGMAR1
SCHEMBL17345917 0.83 SIGMAR1 (0.43) SLC2A1KCNH2CHRM2HTR1AADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS TRIAD NATIONAL SECURITY, LLC 2017-03-30 US disclosed
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS TRIAD NATIONAL SECURITY, LLC 2017-03-30 US disclosed
WO-2015191505-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS LOS ALAMOS NATIONAL SECURITY, LLC (US) 2015-12-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS NANS, NCL, NCLN SLC2A1 3147/4885KCNH2 1753/4885CHRM2 3013/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.